Pacific Biosciences of California Balance Sheet Health
Financial Health criteria checks 3/6
Pacific Biosciences of California has a total shareholder equity of $701.3M and total debt of $892.7M, which brings its debt-to-equity ratio to 127.3%. Its total assets and total liabilities are $1.7B and $1.0B respectively.
Key information
127.3%
Debt to equity ratio
US$892.73m
Debt
Interest coverage ratio | n/a |
Cash | US$634.42m |
Equity | US$701.30m |
Total liabilities | US$1.04b |
Total assets | US$1.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: P09's short term assets ($742.0M) exceed its short term liabilities ($95.0M).
Long Term Liabilities: P09's short term assets ($742.0M) do not cover its long term liabilities ($949.7M).
Debt to Equity History and Analysis
Debt Level: P09's net debt to equity ratio (36.8%) is considered satisfactory.
Reducing Debt: P09's debt to equity ratio has increased from 12.9% to 127.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: P09 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if P09 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.